Enterprise Tech Ecosystem Series: AstraZeneca Plc 2024
Summary
AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection, and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals, and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors, and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa, and Australasia.
The report provides information and insights into AstraZeneca's tech activities, including -
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships and product launches.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets and major ICT contracts.
- The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
- Gain insights into AstraZeneca's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches and partnerships.
- Overview
- Digital Transformation Strategy
- Accelerators, Incubators, and Innovation Programs
- Technology Focus
- Technology Initiatives
- Acquisitions
- Partnership & Acquisition Network Map
- ICT Budget
- Key Executives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook